Evidence map›Paper›PMID 29280429›Full record

ArticleThe American journal of tropical medicine and hygiene2018

Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.

Sofanne J Ravensbergen, Christina Louka, Mariëtte Lokate, Erik Bathoorn, Spyros Pournaras, Tjip S van der Werf, Wiel C M de Lange, Ymkje Stienstra, Onno W Akkerman

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sofanne J RavensbergenUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.
Christina LoukaDepartment of Medical Microbiology, Tzaneio General Hospital of Piraeus, Athens, Greece.
Mariëtte LokateDepartment of Medical Microbiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Erik BathoornDepartment of Medical Microbiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Spyros PournarasDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Tjip S van der WerfDepartment of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Wiel C M de LangeTuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, The Netherlands.
Ymkje StienstraUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.
Onno W AkkermanTuberculosis Center Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, The Netherlands.
University Medical Center Groningen · NLUniversity of Groningen · NLNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A Syrian asylum seeker with multidrug-resistant tuberculosis (TB) developed a bronchopleural fistula after pneumonectomy. Although screening tests were negative on admission, carbapenemase-producing Enterobacteriaceae were cultured after a few months of TB treatment. Prevalence of multidrug-resistant organisms is reported to be increased in asylum seekers compared with the general Dutch population. Arduous conditions during transit and interrupted health care delivery in our patient led to multiple-resistant microorganisms that complicated treatment.

Indexed as

RefugeesAdultAmikacinCarbapenem-Resistant EnterobacteriaceaeClofazimineDrug MonitoringHumansLinezolidMaleMoxifloxacinNetherlandsPrevalenceProthionamideTrimethoprim, Sulfamethoxazole Drug CombinationTuberculosis, Multidrug-ResistantAmikacinClofazimineLinezolidMoxifloxacinProthionamideTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID29280429
PMCPMC5929199
OpenAlexW2778866795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.